Escandon, J., Peacock, S., Trabolsi, A., Thomas, D. B., Layka, A., & Lutzky, J. (2017). Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor. Journal for Immunotherapy of Cancer, 5(1). https://doi.org/10.1186/s40425-016-0205-2

Escandon, Julia, Stephanie Peacock, Asaad Trabolsi, David B. Thomas, Ayman Layka, and Jose Lutzky. “Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.” Journal for Immunotherapy of Cancer 5, no. 1 (December 2017). https://doi.org/10.1186/s40425-016-0205-2.

Escandon J, Peacock S, Trabolsi A, Thomas DB, Layka A, Lutzky J. Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor. Journal for Immunotherapy of Cancer. 2017 Dec;5(1).

Escandon, Julia, et al. “Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.” Journal for Immunotherapy of Cancer, vol. 5, no. 1, BMJ, Dec. 2017. Crossref, doi:10.1186/s40425-016-0205-2.

Escandon J, Peacock S, Trabolsi A, Thomas DB, Layka A, Lutzky J. Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor. Journal for Immunotherapy of Cancer. BMJ; 2017 Dec;5(1).